When Connecticut legalized adult-use cannabis in 2021, lawmakers promised two things: an equitable market for those harmed by the war on drugs and a fair, open marketplace free from monopolies.
Today, it is clear that one of those promises was used to undermine the other. The public was offered a grand bargain: in exchange for giving up our right to basic transparency, the state would receive powerful antitrust tools to prevent a corporate takeover of the market.
That bargain has failed. The antitrust tools have not stopped consolidation, and now the secrecy is being used to hide the very oligopoly it was meant to prevent.
The legalization law, RERACA (An Act Concerning Responsible and Equitable Regulation of Adult-Use Cannabis), was built around this deal. The legislative debate from June 2021 shows the primary goal was to stop “one or two market participants [from] dominat[ing] the entire marketplace”. To do this, the law gave the Attorney General new power to review any “material change” in a license, such as a sale, merger, or new financial “backer”.
But this power came at an enormous cost. In exchange, the legislature wrote an extreme secrecy clause, Connecticut General Statutes § 21a-422k(g), into the law. This provision does two things. First, it makes all filings for cannabis license sales and transfers permanently “exempt from the Connecticut Freedom of Information Act”. Second, it mandates that all sensitive documents “shall be returned” to the filer after the review is complete.
This second point is crucial. It is an information-destruction policy, effectively expunging the public record of who is buying and selling these state-issued licenses.
This trade-off, transparency for enforcement, was based on a premise that has now collapsed. The antitrust review did not stop consolidation. The state’s cannabis market is dominated by a small circle of large Multi-State Operators (MSOs) and their web of partners.
Because the enforcement failed, the secrecy clause has been corrupted. It no longer functions as a shield for the public. It now functions as a shield for the cartel. It allows MSOs to consolidate their control over the market in total darkness, with the state’s own law providing them cover.
This secrecy is most damaging to the law’s primary social goal: equity. The state created “Equity Joint Ventures” (EJVs) to partner social equity applicants with established, capitalized operators. Now, some EJV partners are reportedly lobbying to sell their stakes.
Is this a success story of generational wealth, or is it the final, planned step in a “pass-through” for MSOs to acquire valuable, limited licenses?
The public cannot know. C.G.S. § 21a-422k(g) prevents any public audit of these sales. It leaves us unable to determine if the social equity program is working or if it has simply become a loophole for the very market consolidation the law was meant to prevent.
The original bargain is broken. The justification for secrecy is gone. The legislature must act to repeal this specific confidentiality provision. The ownership of a limited, state-issued license is a public privilege, not a private trade secret. The public has a right to know who owns its cannabis market.